LRRK2 in peripheral and central nervous system innate immunity: Its link to Parkinson's disease

69Citations
Citations of this article
169Readers
Mendeley users who have this article in their library.

Abstract

Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are found in familial and idiopathic cases of Parkinson's disease (PD), but are also associated with immune-related disorders, notably Crohn's disease and leprosy. Although the physiological function of LRRK2 protein remains largely elusive, increasing evidence suggests that it plays a role in innate immunity, a process that also has been implicated in neurodegenerative diseases, including PD. Innate immunity involves macrophages and microglia, in which endogenous LRRK2 expression is precisely regulated and expression is strongly up-regulated upon cell activation. This brief report discusses the current understanding of the involvement of LRRK2 in innate immunity particularly in relation to PD, critically examining its role in myeloid cells, particularly macrophages and microglia.

Cite

CITATION STYLE

APA

Lee, H., James, W. S., & Cowley, S. A. (2017, February 8). LRRK2 in peripheral and central nervous system innate immunity: Its link to Parkinson’s disease. Biochemical Society Transactions. Portland Press Ltd. https://doi.org/10.1042/BST20160262

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free